HomeENTA • NASDAQ
add
Enanta Pharmaceuticals Inc
Previous close
$13.44
Day range
$13.04 - $13.71
Year range
$8.08 - $37.75
Market cap
278.62M USD
Avg Volume
219.64K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 18.00M | -23.67% |
Operating expense | 52.89M | -1.32% |
Net income | -33.41M | -15.25% |
Net profit margin | -185.56 | -50.98% |
Earnings per share | -1.58 | -13.67% |
EBITDA | -34.24M | -16.07% |
Effective tax rate | 1.83% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 337.15M | 57.20% |
Total assets | 428.50M | 23.30% |
Total liabilities | 236.62M | 406.70% |
Total equity | 191.88M | — |
Shares outstanding | 21.16M | — |
Price to book | 1.48 | — |
Return on assets | -19.58% | — |
Return on capital | -20.62% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -33.41M | -15.25% |
Cash from operations | -24.99M | 29.89% |
Cash from investing | -13.12M | -139.07% |
Cash from financing | -7.35M | -2,541.86% |
Net change in cash | -45.46M | -2,466.63% |
Free cash flow | -17.78M | 37.48% |
About
Founded
1995
Headquarters
Website
Employees
145